Many accidental cases of carbon monoxide poisoning result from the incomplete combustion of household gas.' We describe an unusual cause of carbon monoxide intoxication affecting several elderly neighbours in a former mining town.
Comment
Patients with Crohn's disease and severe malnutrition are often amenorrhoeic and subfertile. Though home parenteral nutrition was effective in correcting malnutrition and restoring a high quality of life in this case it did not affect the amenorrhoea. Our main problem was a total lack of information on intravenous nutritional requirements in pregnancy. We were able to measure direct the requirements for amino acids and energy, but the need for minerals, trace elements, and vitamins was more difficult to determine. Our ultimate dosage regimen was only marginally different from that given to normal patients during pregnancy.
Despite Heller's assertions2 that fat emulsions are contraindicated in pregnancy, neither patient nor baby showed ill effects from administration of lipids. Similarly, Heller's suggestion that intravenous fat emulsion may induce premature labour is not borne out by this case.
The low birth weight of the baby may be a result of inadvertent temporary reduction in energy intake during early pregnancy when an increase would have been more appropriate. Our 1977 and 1979 with conventional immunosuppression had failed. She conceived in November 1981 when receiving cyclosporin A 450 mg daily, which was continued at the same dose throughout the pregnancy. She remained normotensive with no proteinuria. Concentrations of serum creatinine (mean 98-5 SD 6-0 tzmol/l; l 1-SD 0 I mg/100 ml) and urea (mean 7-8± SD 1-5 mmol/l; 46-7 SD 9-2 mg/100 ml) remained stable, and the white cell count (mean 7-4A SD 1-3 X 109/1) and platelet count were within normal limits. Haemoglobin concentration varied between 9-6 and 12-2 g/dl.
Serial ultrasound cephalometry confirmed satisfactory fetal growth, and regular antenatal fetal heart tracings were normal. A placental lactogen estimation at 33 weeks of gestation was 9 4 mg/l, but serial 24 hour urinary oestriol estimations carried out from 32 weeks were persistently below normal limits. Labour was induced at 38 weeks of pregnancy and a healthy boy weighing 2980 g delivered vaginally. The fetal heart rate remained stable throughout labour, and the Apgar score at five minutes was 9. The baby had a haemoglobin concentration of 15-9 g/dl and a white cell count of 23-4 ± 199/1, and careful clinical examination showed no hirsutism or congenital abnormality. Bilirubin concentration did not rise above 155 iLmol/l (9.1 mg/100 ml) and aspartate transaminase activity was normal (56 IU/1). The patient was advised against breast feeding because of the possible transfer of cyclosporin A into the breast milk. Mother and baby were allowed home on the seventh postpartum day.
Cyclosporin A was not detected in specimens of liquor obtained at amniocentesis at 36 weeks and at amniotomy, but this was not surprising given the very low water solubility of the drug. The drug was present in the maternal and cord blood at delivery in concentrations of 86 and 54 [sg/l, respectively. Cyclosporin A was also detected in samples of breast milk obtained on days 2 (101 ,ug/l), 3 (109 ,ug/l), and 4 (263 Hg/l) post partum. Maternal blood samples were not taken simultaneously with the milk samples, however, so that we could not calculate the distribution ratio between blood and milk.
Reports indicate that women with a well functioning renal transplant have a reasonable chance of delivering a healthy infant. There is, however, a small risk of congenital abnormality and fetal adrenal suppression when the mother is taking steroids2 and azathioprine. 3 The fungal peptide cyclosporin A has a selective action against T cells, particularly those concerned in allograft rejection, and reports on the use of the drug in clinical renal transplantation have confirmed its powerful immunosuppressive properties. 4 Studies in animals have not shown any teratogenicity of cyclosporin A, and the results in our case confirm that although the drug crossed the placenta there was no evidence of immunosuppression or congenital abnormality in the baby.
Interestingly urinary oestriol concentrations were persistently low while other parameters of fetal wellbeing were satisfactory. This has been reported in other renal transplant recipients and was presumed to be due to fetal adrenal suppression caused by steroid administration to the mother. We found that oestriol concentrations in urine specimens of other pregnant women were not reduced when mixed with urine from patients taking cyclosporin A, thus indicating that this drug does not interfere with urine oestriol determinations. The low urinary oestriol excretion in pregnant renal transplant recipients may therefore be due to a relatively lower glomerular filtration rate.
Studies in animals show that cyclosporin A is excreted in breast milk in a maximum amount of 2% of the maternal dose (M Lemaire, unpublished Sandoz internal document, 1982), and this was confirmed by the detection of appreciable quantities of the drug in the breast milk of our patient. We therefore suggest that mothers taking cyclosporin A should avoid breast feeding. Our findings suggest that we can be reasonably optimistic about the outcome of pregnancy in patients with a well functioning renal transplant receiving cyclosporin A, and because there is no evidence of teratogenicity cyclosporin A may be the drug of choice in renal transplant recipients contemplating pregnancy. We recommend that patients should avoid pregnancy for two years after transplantation because of the increased risk of graft rejection during this period, and by two years patients will have reached their lowest immunosuppressive maintenance doses.
